Leukocyte count, a widely available and inexpensive clinical marker of inflammation, may help predict the severity of long COVID symptoms in postmenopausal women, researchers reported.
As the Trump administration issued an abrupt pause to federal financial assistance, the move threatened billions in grants ...
A new memo by NIH Acting Director Matthew Memoli, obtained by Forbes, clarifies what can and can’t be done with regard to ...
Despite concerns about the future of research at the National Institutes of Health, current clinical trials can continue as ...
Just days after President Trump imposed broad restrictions on communications, meetings, travel and public appearances at the ...
Scientists at the National Institutes of Health have been told the communications pause announced by the Trump Administration ...
At Fred Hutch Cancer Center, our Phase 1 Clinical Trials Program includes patients with ... The National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH), did a survey ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback